Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / #OTHER
-
Shares outstanding
-
67M
-
Number of holders
-
74
-
Total 13F shares, excl. options
-
57.2M
-
Shares change
-
-95K
-
Total reported value, excl. options
-
$217M
-
Value change
-
-$1.31M
-
Put/Call ratio
-
2.56
-
Number of buys
-
26
-
Number of sells
-
-33
-
Price
-
$3.79
Significant Holders of Generation Bio Co. - #OTHER (GBIO) as of Q3 2023
83 filings reported holding GBIO - Generation Bio Co. - #OTHER as of Q3 2023.
Generation Bio Co. - #OTHER (GBIO) has 74 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 57.2M shares
of 67M outstanding shares and own 85.34% of the company stock.
Largest 10 shareholders include FMR LLC (8.43M shares), Atlas Venture Life Science Advisors, LLC (8.28M shares), PRICE T ROWE ASSOCIATES INC /MD/ (7.45M shares), Bellevue Group AG (3.62M shares), T. Rowe Price Investment Management, Inc. (3.51M shares), BlackRock Inc. (3.35M shares), Artal Group S.A. (2.81M shares), PFM Health Sciences, LP (2.51M shares), VANGUARD GROUP INC (2.34M shares), and EcoR1 Capital, LLC (2.05M shares).
This table shows the top 74 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.